GGrantIndex
← Leaderboards

Michael O Thorner

University Of Virginia Charlottesville

$7,721,062
Attributed
$7,721,062
Total exposure
21
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $711.7K · FY200512
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12

Funding mix

By agency

NIH$7,721,062 · 21

By mechanism

R01$3,937,083 · 2
M01$3,783,979 · 19

Top collaborators

No co-investigators on record.

Most similar at University Of Virginia Charlottesville

Same institution · by research overlap

Others in their field

Top investigators on “Somatotropin

Research focus

SomatotropinHuman SubjectHormone Regulation /Control MechanismClinical ResearchAge DifferenceSecretionFastingHuman Old Age (65+)Growth Hormone Releasing HormoneAgingEndocrine PharmacologySomatostatinYoung Adult Human (21-34)DosageHormone TherapyPeptide HormoneHormone ReceptorPeptide Hormone AnalogCircadian RhythmsHuman Therapy EvaluationInsulinlike Growth FactorEatingBody CompositionInsulin

Grant awards (58)

Ghrelin Regulation: Implications for Understanding Obesity$540,558
R01 · FY2012 · DK · contact PI
Ghrelin Regulation: Implications for Understanding Obesity$540,558
R01 · FY2011 · DK · contact PI
Ghrelin Regulation: Implications for Understanding Obesity$546,018
R01 · FY2010 · DK · contact PI
RELATION OF ACYL- AND DES-ACYL GHRELIN SECRETION AND PLASMA INSULIN, CORTISOL,GH$165,714
M01 · FY2010 · RR · contact PI
Ghrelin Regulation: Implications for Understanding Obesity$535,468
R01 · FY2009 · DK · contact PI
RELATION OF ACYL- AND DES-ACYL GHRELIN SECRETION AND PLASMA INSULIN, CORTISOL,GH$110,165
M01 · FY2009 · RR · contact PI
Ghrelin Regulation: Implications for Understanding Obesity$15,000
R01 · FY2009 · DK · contact PI
Ghrelin Regulation: Implications for Understanding Obesity$531,071
R01 · FY2008 · DK · contact PI
EFFECT OF FASTING ON GHRELIN AND GH SECRETION IN HEALTHY YOUNG AND OLDER ADULTS$138,652
M01 · FY2005 · RR
METFORMIN TREATMENT IN HEALTHY OLDER ADULTS$24,421
M01 · FY2005 · RR
MOT089 MK-677 IN OLDER MEN AND WOMEN$18,907
M01 · FY2005 · RR
IGF-GENERATION TEST FOR GH-INSENSITIVITY IN A PT WITH NORMAL GH STIM/LOW IGF-I$1,576
M01 · FY2005 · RR
MOT089 MK-677 in Older Men and Women$661,131
M01 · FY2004 · RR
Effect Of Fasting On Ghrelin And GH Secretion In Adults$302,427
M01 · FY2004 · RR
Metformin Treatment In Healthy Older Adults$153,421
M01 · FY2004 · RR
GH Response to Various Doses of GHRH in Healthy Young and Older Adults$6,623
M01 · FY2004 · RR
REVERSAL OF DECLINE OF GH SECRETION OF AGING$376,623
R01 · FY2002 · DK
REVERSAL OF DECLINE OF GH SECRETION OF AGING$124,326
R01 · FY2002 · DK
EFFECTS OF LEPTIN ON GH$48,533
M01 · FY2002 · RR
GH RECEPTOR ANTAGONIST B2036-PEG AND GH SECRETION$48,533
M01 · FY2002 · RR
MOT089 EFFECT OF GRADED SRIH INFUSION ON GH RELEASE IN FASTED SUBJECTS$48,533
M01 · FY2002 · RR
GH RESPONSE TO VARIOUS DOSES OF GHRH IN HEALTHY YOUNG AND OLDER ADULTS$48,533
M01 · FY2002 · RR
GROWTH HORMONE SECRETION &BODY COMPOSITION MEASUREMENT IN ADULTS$48,533
M01 · FY2002 · RR
INVESTIGATION OF CLINICAL AND HORMONAL EFFECTS OF SOMATOSTATIN ANALOGUE$48,533
M01 · FY2002 · RR
ASSAY ONLY GH MEASUREMENTS IN GHRH RECEPTOR MUTATION$48,533
M01 · FY2002 · RR
REVERSAL OF DECLINE OF GH SECRETION OF AGING$368,063
R01 · FY2001 · DK
GH RECEPTOR ANTAGONIST B2036-PEG AND GH SECRETION$48,533
M01 · FY2001 · RR
INVESTIGATION OF CLINICAL AND HORMONAL EFFECTS OF SOMATOSTATIN ANALOGUE$48,533
M01 · FY2001 · RR
GROWTH HORMONE SECRETION &BODY COMPOSITION MEASUREMENT IN ADULTS$48,533
M01 · FY2001 · RR
GH RESPONSE TO VARIOUS DOSES OF GHRH IN HEALTHY YOUNG AND OLDER ADULTS$48,533
M01 · FY2001 · RR
MOT089 EFFECT OF GRADED SRIH INFUSION ON GH RELEASE IN FASTED SUBJECTS$48,533
M01 · FY2001 · RR
EFFECTS OF LEPTIN ON GH$48,533
M01 · FY2001 · RR
ASSAY ONLY GH MEASUREMENTS IN GHRH RECEPTOR MUTATION$48,533
M01 · FY2001 · RR
REVERSAL OF DECLINE OF GH SECRETION OF AGING$359,398
R01 · FY2000 · DK
24-HOUR PROFILES OF GH SECRETION AND GH RESPONSE TO GHRP IN ACROMEGALY$248,088
M01 · FY2000 · RR
MOT093--GH IN TREATED ACROMEGALY ASSAY ONLY$248,088
M01 · FY2000 · RR
ARGININE AND IGF-1 IN FASTED YOUNG ADULTS$248,088
M01 · FY2000 · RR
EFFECT OF ARGININE AND FASTING ON GH SECRETION IN YOUNG AND OLDER ADULTS$248,088
M01 · FY2000 · RR
EFFECT OF INSULINLIKE GROWTH FACTOR-I ON GH SECRETION IN TYPE I DIABETES$248,088
M01 · FY2000 · RR
MOT089 EFFECT OF GRADED SRIH INFUSION ON GH RELEASE IN FASTED SUBJECTS$28,104
M01 · FY2000 · RR
GH RESPONSE TO VARIOUS DOSES OF GHRH IN HEALTHY YOUNG AND OLDER ADULTS$28,104
M01 · FY2000 · RR
EFFECT OF INSULINLIKE GROWTH FACTOR-I ON GH SECRETION IN TYPE I DIABETES$28,104
M01 · FY2000 · RR
24-HOUR PROFILES OF GH SECRETION AND GH RESPONSE TO GHRP IN ACROMEGALY$28,104
M01 · FY2000 · RR
GROWTH HORMONE SECRETION &BODY COMPOSITION MEASUREMENT IN ADULTS$28,104
M01 · FY2000 · RR
MOT093--GH IN TREATED ACROMEGALY ASSAY ONLY$28,104
M01 · FY2000 · RR
ARGININE AND IGF-1 IN FASTED YOUNG ADULTS$28,104
M01 · FY2000 · RR
EFFECTS OF LEPTIN ON GH$28,104
M01 · FY2000 · RR
EFFECT OF ARGININE AND FASTING ON GH SECRETION IN YOUNG AND OLDER ADULTS$28,104
M01 · FY2000 · RR
INVESTIGATION OF CLINICAL AND HORMONAL EFFECTS OF SOMATOSTATIN ANALOGUE$28,104
M01 · FY2000 · RR
EFFECTS OF LEPTIN ON GH$0
M01 · FY2000 · RR
GH RECEPTOR ANTAGONIST B2036-PEG AND GH SECRETION$0
M01 · FY2000 · RR
GH RECEPTOR ANTAGONIST B2036-PEG AND GH SECRETION$0
M01 · FY2000 · RR
MOT089 EFFECT OF GRADED SRIH INFUSION ON GH RELEASE IN FASTED SUBJECTS$0
M01 · FY2000 · RR
INVESTIGATION OF CLINICAL AND HORMONAL EFFECTS OF SOMATOSTATIN ANALOGUE$0
M01 · FY2000 · RR
GH RESPONSE TO VARIOUS DOSES OF GHRH IN HEALTHY YOUNG AND OLDER ADULTS$0
M01 · FY2000 · RR
ASSAY ONLY GH MEASUREMENTS IN GHRH RECEPTOR MUTATION$0
M01 · FY2000 · RR
ASSAY ONLY GH MEASUREMENTS IN GHRH RECEPTOR MUTATION$0
M01 · FY2000 · RR
GROWTH HORMONE SECRETION &BODY COMPOSITION MEASUREMENT IN ADULTS$0
M01 · FY2000 · RR